Ranbaxy launches generic olanzapine tablets, in spain, on day-1 following...
Ranbaxy Laboratories Limited (Ranbaxy) today announced the Day-1 launch of Olanzapine Tablets, the generic version of Zyprexa. Ranbaxy will be introducing Olanzapine tablets 2.5mg, 5mg, 7.5mg and 10mg...
View ArticleRanbaxy UK ltd. Launches esomeprazole
Ranbaxy (UK) Ltd. announced that it has successfully launched esomeprazole 20 mg and 40 mg tablets, the first approved generic bio-equivalent version of the product NexiumTM, in the United Kingdom...
View ArticleDAIICHI SANKYO AND RANBAXY TO LEVERAGE SYNERGIES IN THAILAND
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and Ranbaxy Laboratories Limited (Ranbaxy) today announced their intention to integrate their business operations in Thailand, to leverage and maximize...
View ArticleRanbaxy to market Desvenlafaxine Base Extended Release Tablets in The US
Enters into an in-licensing business agreement with Alembic Gurgaon, India, March 05, 2013: Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),...
View ArticleDaiichi Sankyo and Ranbaxy launch hybrid business in Brazil to expand...
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Ranbaxy Laboratories Limited (hereafter, Ranbaxy) today announced synergy in Brazil to expand the business of both companies in the...
View ArticleRANBAXY Response to CBS Evening News Report
Princeton, New Jersey – On November 5th and 6th, CBS Network News aired a report that focused on Ranbaxy generic medications produced in India. Unfortunately, this report conveyed broad speculation...
View Article
More Pages to Explore .....